trial

A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression

NCTId NCT00481026
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 31 (actual)
Sponsored by Bayside Health
Primary completion 2013-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
31 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2007-08
Primary completion
2013-05
Eligibility
ALL · 18 Years · 75 Years

Interventions & indications

Drugs
transcranial direct current stimulation (tDCS)Active TDCS

Sponsors

Bayside HealthLead Sponsor

Investigators

1
Paul B Fitzgerald, MBBS, MPM, PhD, FRANZCPPrincipal Investigator

Sites

1 total
Prahran, Australia

Facts & assertions

4 sourced
Enrollment
31
Phase
NA
Primary Completion Date
2013-05
Status
COMPLETED
relationships
The graph out of here
drug
transcranial direct current stimulation (tDCS)
drug
Active TDCS
drug
lead_sponsor
Bayside Health
company
indication
Schizophrenia
indication
Major Depression
indication
Schizophrenia
indication
investigator
Paul B Fitzgerald, MBBS, MPM, PhD, FRANZCP
person